WINTON GROUP Ltd Sells 35,454 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• WINTON GROUP Ltd cut its UnitedHealth Group stake by 95.4% in the second quarter, selling 35,454 shares and retaining 1,701 shares valued at approximately $707,000.
• Analysts maintain a broadly positive outlook, with a consensus “Moderate Buy” rating and an average price target of $456.56.
• UnitedHealth exceeded quarterly earnings expectations with $6.38 in EPS and $112.03 billion in revenue, while announcing a quarterly dividend of $2.32 per share, equal to a 2.4% yield.

WINTON GROUP Ltd trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 95.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,701 shares of the healthcare conglomerate's stock after selling 35,454 shares during the quarter. WINTON GROUP Ltd's holdings in UnitedHealth Group were worth $707,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. California State Teachers Retirement System raised its holdings in UnitedHealth Group by 41,749.2% during the 2nd quarter. California State Teachers Retirement System now owns 567,446,754 shares of the healthcare conglomerate's stock valued at $235,847,894,000 after buying an additional 566,090,823 shares during the period. Norges Bank purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $4,376,167,000. Corient Private Wealth LP purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth about $245,516,000. Legal & General Group Plc purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $2,444,928,000. Finally, Jupiter Topco LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at approximately $2,019,844,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on UNH shares. Leerink Partners boosted their price objective on UnitedHealth Group from $400.00 to $462.00 and gave the company an "outperform" rating in a report on Wednesday, June 17th. Bank of America reissued a "buy" rating on shares of UnitedHealth Group in a research note on Monday, July 20th. JPMorgan Chase & Co. raised their price target on shares of UnitedHealth Group from $466.00 to $516.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 21st. HSBC upped their target price on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a "hold" rating in a research note on Monday, July 6th. Finally, BMO Capital Markets set a $512.00 price target on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $456.56.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $383.23 on Tuesday. The company has a market cap of $343.99 billion, a P/E ratio of 24.66, a PEG ratio of 1.43 and a beta of 0.61. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The stock's 50-day moving average is $407.88 and its 200 day moving average is $369.08. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating analysts' consensus estimates of $4.94 by $1.44. The business had revenue of $112.03 billion for the quarter, compared to analysts' expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company's revenue was up .4% compared to the same quarter last year. During the same period last year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be issued a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group's dividend payout ratio is currently 59.72%.

Insiders Place Their Bets

In related news, CEO Patrick Conway sold 1,169 shares of the business's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.19% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.